Fukagawa M - Search Results

1

Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.

Goto S, Komaba H, Moriwaki K, Fujimori A, Shibuya K, Nishioka M, Kim JI, Yoshiya K, Shin J, Hasegawa H, Taniguchi M, Fujii H, Nishi S, Kamae I, Fukagawa M. Goto S, et al. Among authors: fukagawa m. Clin J Am Soc Nephrol. 2011 Jun;6(6):1375-84. doi: 10.2215/CJN.08841010. Epub 2011 May 5. Clin J Am Soc Nephrol. 2011. PMID: 21551021 Free PMC article. Clinical Trial.

2

Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.

Nakanishi S, Yano S, Nomura R, Tsukamoto T, Shimizu Y, Shin J, Fukagawa M. Nakanishi S, et al. Among authors: fukagawa m. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii47-9. doi: 10.1093/ndt/gfg1012. Nephrol Dial Transplant. 2003. PMID: 12771300 Review.

3

[Skeletal complications of renal insufficiency].

Fujimori A, Fukagawa M. Fujimori A, et al. Among authors: fukagawa m. Nihon Rinsho. 2004 Feb;62 Suppl 2:706-10. Nihon Rinsho. 2004. PMID: 15035213 Review. Japanese. No abstract available.

4

Study of plasma exchange for liver failure: beneficial and harmful effects.

Abe T, Kobata H, Hanba Y, Kitabata Y, Narukawa N, Hasegawa H, Abe T, Fukagawa M. Abe T, et al. Among authors: fukagawa m. Ther Apher Dial. 2004 Jun;8(3):180-4. doi: 10.1111/j.1526-0968.2004.00149.x. Ther Apher Dial. 2004. PMID: 15154867 Clinical Trial.

5

Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.

Fujimori A, Sakai M, Yoshiya K, Shin J, Kim JI, Inaba Y, Miyamoto T, Inoue S, Fukagawa M. Fujimori A, et al. Among authors: fukagawa m. Ther Apher Dial. 2004 Dec;8(6):474-9. doi: 10.1111/j.1774-9987.2004.00189.x. Ther Apher Dial. 2004. PMID: 15663547

6

Control of parathyroid function in patients with a short history of hemodialysis.

Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M. Nishi H, et al. Among authors: fukagawa m. Ther Apher Dial. 2005 Feb;9(1):39-43. doi: 10.1111/j.1774-9987.2005.00212.x. Ther Apher Dial. 2005. PMID: 15828904 Clinical Trial.

7

Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism.

Nishi H, Nii-Kono T, Nakanishi S, Yamazaki Y, Yamashita T, Fukumoto S, Ikeda K, Fujimori A, Fukagawa M. Nishi H, et al. Among authors: fukagawa m. Nephron Clin Pract. 2005;101(2):c94-9. doi: 10.1159/000086347. Epub 2005 Jun 14. Nephron Clin Pract. 2005. PMID: 15956805

8

[Effects of reduced dialysate calcium on mineral metabolism in hemodialysis patients].

Fujimori A, Yorifuji M, Sakai M, Fukagawa M. Fujimori A, et al. Among authors: fukagawa m. Clin Calcium. 2005 Sep;15 Suppl 1:121-4; discussion 124. Clin Calcium. 2005. PMID: 16272643 Japanese.

9

Clinical implications of assessing coronary flow velocity reserve and plasma endothelin-1 in hypertensive patients.

Fujii H, Takiuchi S, Kamide K, Horio T, Niizuma S, Tanaka N, Hashimoto S, Nakatani S, Fukagawa M, Kawano Y. Fujii H, et al. Among authors: fukagawa m. Hypertens Res. 2005 Nov;28(11):911-6. doi: 10.1291/hypres.28.911. Hypertens Res. 2005. PMID: 16555580

10

Regulation of parathyroid function in chronic kidney disease (CKD).

Fukagawa M, Nakanishi S, Fujii H, Hamada Y, Abe T. Fukagawa M, et al. Clin Exp Nephrol. 2006 Sep;10(3):175-9. doi: 10.1007/s10157-006-0432-9. Clin Exp Nephrol. 2006. PMID: 17009074 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters